University of Michigan researchers are exploring a new approach to treating antiphospholipid syndrome (APS), an autoimmune disease best known for causing blood clots. This study focuses on a lesser-known but serious complication: APS vasculopathy, marked by abnormal thickening of blood vessel walls. Read the full article to learn how this work could pave the way for better understanding and future treatment options.
